摘要:
The present invention relates to heterocyclic compounds, characterized in that they have the general formula I ##STR1## Wherein Ar, n and Z.sub.1 -Z.sub.6 are defined in the specification, are disclosed to have pharmaceutical activity on the central nervous system.
摘要:
The present invention relates to heterocyclic compounds, characterized in that they have the general formula I ##STR1## wherein Ar, n, and Z.sub.1 and Z.sub.6 are defined in the specification, are disclosed to have pharmaceutical activity on the central nervous system.
摘要:
The present invention relates to a process for the preparation of aryl (or heteroaryl) piperazinyl-butylazole derivatives corresponding to the general formula I ##STR1## in which Ar denotes a nitrogenous or other aromatic radical chosen from differently substituted aryls, differently substituted 2-pyrimidine, 2-N-methyl-imidazole and 3-(1,2-benzisothiazole)Z.sub.1 denotes a nitrogen atom or an optionally substituted carbon atom which may be denoted by: C-R.sub.1Z.sub.2 denotes a nitrogen atom or an optionally substituted carbon atom which may be denoted by: C-R.sub.2Z.sub.4 denotes a nitrogen atom or an optionally substituted carbon atom which may be denoted by: C-R.sub.4 and R.sub.1, R.sub.2, R.sub.3 and R.sub.4, which are identical or different and may also form a part of another ring, aromatic or otherwise, denote a hydrogen atom, a halogen, a lower alkyl radical, a nitro radical, a hydroxyl radical, an alkoxy radical, a cyano radical, a carboxylic radical, a carboxamido radical, an alkylcarboxylate radical, an aryl or substituted aryl radical, a sulfonic radical, a sulfonamido radical optionally substituted on the amino group or an amino or substituted amino radicalwherein ##STR2## in which Ar has the meanings referred to above and X denotes a halogen atom, is reacted with a compound of general formula III ##STR3## in which Z.sub.1, Z.sub.2, Z.sub.4 and R.sub.3 have the meanings referred to above.
摘要翻译:本发明涉及一种制备相应于通式I(I)的芳基(或杂芳基)哌嗪基 - 丁唑衍生物的方法,其中Ar表示选自不同取代的芳基的含氮或其它芳族基团, 2-嘧啶,2-N-甲基咪唑和3-(1,2-苯并异噻唑)Z1表示氮原子或任选取代的碳原子,可以用以下表示:C-R 1 Z 2表示氮原子或任选取代的 碳原子,其可以由以下表示:C-R 2 Z 4表示氮原子或任选取代的碳原子,其可以由以下表示:C-R 4和R 1,R 2,R 3和R 4,其相同或不同,并且也可以形成 另一个芳环或其它环的一部分表示氢原子,卤素,低级烷基,硝基,羟基,烷氧基,氰基,羧基,甲酰胺基,烷基羧酸根, 芳基或取代基 在氨基或氨基或取代的氨基上任选取代的磺酰基,磺酰氨基,其中Ar具有上述含义,X表示卤素原子的氨基或取代的氨基,与其反应,与 其中Z1,Z2,Z4和R3具有上述含义的通式III的化合物(III)。
摘要:
The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
摘要:
The present invention relates to new derivatives of sulphonamides, with the general formula (I), as well as to their physiologically acceptable salts, the processes for their preparation, their application as medicaments in human and/or veterinary therapy and the pharmaceutical compositions that contain them.
摘要:
The present invention makes reference to new indene derivatives with general formula (I), as well as to their preparation procedures, their application as medicament and the pharmaceutical compositions containing them. The new compounds of formula (I) show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
摘要:
The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula I show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.
摘要:
Derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols of formula (I), wherein R1, R2 and R3, which are similar or different, represent each of them hydrogen, halogen, alkyl C1-C4, trifluoromethyl, hydroxyl, alkoxyl, or two adjacent radicals can form a ring; A is a C atom and the dotted line represents an additional bond, or A is a C atom joined to a hydroxyl group and the dotted line represents absence of additional bond; Z1 is N or CR4; Z2 is N or CR5; Z4 is N or CR7; and R4, R5, R6 and R7, which different, represent hydrogen, halogen, alkyl C1-C4, aryl or substituted aryl, or two adjacent radicals can form part of another ring. These derivatives are useful for the treatment of acute pain, neuropathic pain or nociceptive pain in mammals, including human beings.
摘要:
Methods for preparing 2-(4-(4-(4,5-dichloro-2-methylimidazol-1yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and its physiologically acceptable salts are disclosed.
摘要:
The present invention refers to new indanyl sulphonamide compounds with general formula (I), as well as to their preparation procedure, their application as medicine and the pharmaceuticals composition which they are made up of. The new compounds of formula I show affinity for 5-HT6 receptors and are, therefore, effective for treating diseases mediated by these receptors.